Wang, Fu-Sheng
Chinese PLA General Hospital
9 papers on CoChatORCID 0000-0002-8043-6685
Most cited papers
- Verified
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine
COVID-19 Clinical Research StudiesRespiratory Support and Mechanisms
Cited by 8,545
- Verified
Increased Regulatory T Cells Correlate With CD8 T-Cell Impairment and Poor Survival in Hepatocellular Carcinoma Patients
Fu, J., Xu, D., Liu, Z., Shi, M., Zhao, P., Fu, B., Zhang, Z., Yang, H., Zhang, H., Zhou, C., et al. (2007) · Gastroenterology
T-cell and B-cell ImmunologyHepatocellular Carcinoma Treatment and Prognosis
Cited by 897
- Verified
COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas
Ren, X., Wen, W., Fan, X., Hou, W., Su, B., Cai, P., Li, J., Liu, Y., Tang, F., Zhang, F., et al. (2021) · Cell
Single-cell and spatial transcriptomicsCOVID-19 Clinical Research Studies
Cited by 865
- Verified
A pilot study of umbilical cord‐derived mesenchymal stem cell transfusion in patients with primary biliary cirrhosis
Wang, L., Li, J., Liu, H., Li, Y., Fu, J., Sun, Y., Xu, R., Lin, H., Wang, S., Lv, S., et al. (2013) · Journal of Gastroenterology and Hepatology
Liver Diseases and ImmunityMesenchymal stem cell research
Cited by 195
- Verified
Mesenchymal stem cell therapy in decompensated liver cirrhosis: a long-term follow-up analysis of the randomized controlled clinical trial
Shi, M., Li, Y.-Y., Xu, R.-N., Meng, F.-P., Yu, S.-J., Fu, J.-L., Hu, J.-H., Li, J.-X., Wang, L.-F., Jin, L., et al. (2021) · Hepatology International
Mesenchymal stem cell researchLiver Disease and Transplantation
Cited by 151
- Verified
APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis
You, H., Ma, X., Efe, C., Wang, G., Jeong, S.-H., Abe, K., Duan, W., Chen, S., Kong, Y., Zhang, D., et al. (2022) · Hepatology International
Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments
Cited by 133
- Verified
B and T Lymphocyte Attenuator Down-regulation by HIV-1 Depends on Type I Interferon and Contributes to T-Cell Hyperactivation
Zhang, Z., Xu, X., Lu, J., Zhang, S., Gu, L., Fu, J., Jin, L., Li, H., Zhao, M., Zhang, J., et al. (2011) · The Journal of Infectious Diseases
HIV Research and TreatmentT-cell and B-cell Immunology
Cited by 35
- Verified
Dose-escalation studies of mesenchymal stromal cell therapy for decompensated liver cirrhosis: phase Ia/Ib results and immune modulation insights
Shi, L., Zhang, Z., Mei, S., Wang, Z., Xu, Z., Yao, W., Liu, L., Yuan, M., Pan, Y., Zhu, K., et al. (2025) · Signal Transduction and Targeted Therapy
Mesenchymal stem cell researchLiver Disease and Transplantation
Cited by 16
- Verified
MRI/PAI Dual-modal Imaging-guided Precise Tracking of Bone Marrow-derived Mesenchymal Stem Cells Labeled with Nanoparticles for Treating Liver Cirrhosis
Liu, F.-Y., Shi, M., Li, X., Yuan, H.-J., Tian, X.-M., Xia, Y.-M., Zhou, M., & Wang, F.-S. (2022) · Journal of Clinical and Translational Hepatology
Mesenchymal stem cell researchLiver physiology and pathology
Cited by 3
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free